ERCP Clinical Trial
— ERCPOfficial title:
Registro Delle Colangiopancreatografie Retrograde Endoscopiche Eseguite in Humanitas
NCT number | NCT04661332 |
Other study ID # | 2143 |
Secondary ID | |
Status | Recruiting |
Phase | |
First received | |
Last updated | |
Start date | January 1, 2016 |
Est. completion date | December 31, 2025 |
Treatment of the pathology of the extrahepatic biliary tract is the most frequent indication for performing endoscopic retrograde cholangiography (ERCP). The method, which combines endoscopic and radiological vision, also allows for therapeutic (and diagnostic) procedures on some pathologies of the pancreas and the papilla of Vater. During the maneuvers it is also possible to obtain cyto-histological material for the diagnosis of any lesions identified, through the execution of brushing. The endoscope used for ERCP allows for microsurgical procedures to be performed on the papilla of Vater, on the biliary tract and on the pancreas, procedures that in the past required a real surgical intervention. ERCP is a generally well tolerated procedure, but as with all medical procedures it can have limitations and be followed by some complications. In 5% of cases, the procedure may not be completed due to anatomical variants that do not allow the endoscope to reach the duodenum or to cannulate and visualize the bile and / or pancreatic ducts. The most frequent complication is acute pancreatitis, which can arise as a consequence of surgery on the common outlet of the biliary and pancreatic tracts; it occurs in 3-5% of cases and to date, it cannot be predicted or prevented in all cases. In some groups of patients (young, with non-dilated biliary tract, or with a history of previous pancreatitis) the risk of pancreatitis can reach 10-12% . In rare cases (less than 1%), pancreatitis can have a severe course and may require surgery. Other less frequent complications (with an overall incidence of less than 2%) are: infection of the biliary tract or cystic collections, bleeding resulting from papillo-sphincterotomy, and perforation of the duodenum or ducts. Infection and bleeding are generally treated medically or endoscopically; the perforation may require surgery in some cases. This registry aims to collect in a prospective and / or retrospective way the data of the ERCP procedures performed in our center by evaluating the sex, age of the patient, the reason why the patient was subjected to the examination, diagnosis, clinical risk factors and technical risk (i.e. associated with the procedure itself), if there have been complications, the type of instrumentation in use in our operating unit and / or the operators performing the examinations.
Status | Recruiting |
Enrollment | 5000 |
Est. completion date | December 31, 2025 |
Est. primary completion date | December 31, 2025 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - All patients will be recruited at the ICH Gastroenterology and Digestive Endoscopy Unit. The patients in question will be subjects of both sexes, over the age of 18 and who need to undergo ERCP. Exclusion Criteria: - Patients under 18 or unable to express informed consent. |
Country | Name | City | State |
---|---|---|---|
Italy | Humanitas Research Hospital | Rozzano |
Lead Sponsor | Collaborator |
---|---|
Istituto Clinico Humanitas |
Italy,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | To collect the information of all the ERCPs performed in the hospital | This study aims to collect the information of all the ERCPs performed in the hospital in order to know the current clinical practice in order to identify any margins for improvement | 10 years |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02041390 -
Effect of Short Message Service Intervention on Stent Removal/Exchange Adherence in Patients With Benign Pancreaticobiliary Diseases
|
N/A | |
Completed |
NCT04619511 -
Risk Factors for Post-ESWL and Post-ERCP Pancreatitis
|
||
Terminated |
NCT00419549 -
Efficacy Study of Glyceryl-Trinitrate Patch and Parecoxib (Valdecoxib) for the Prevention of Pancreatitis After Endoscopic Retrograde Cholangiopancreatography (ERCP)
|
Phase 2/Phase 3 | |
Recruiting |
NCT04255095 -
Early Intervention of High Tension in the Pancreatic Duct on the Outcome of Severe Biliary Pancreatitis
|
N/A | |
Completed |
NCT05220774 -
Conscious Sedation Versus Anesthesia for ERCP
|
||
Completed |
NCT03698266 -
Is Needle Knife Fistulotomy An Effective First Step Strategy For All ERCPs?
|
N/A | |
Recruiting |
NCT03350555 -
Clinical Trials to Validate the Use of Additioned Endoscopy in Endoscopic Retrograde Cholangiopancreatography
|
N/A | |
Completed |
NCT04671095 -
Single Use ERCP Performance -SURE Study
|
||
Recruiting |
NCT05603702 -
STTEPP: Safety, Tolerability and Dose Limiting Toxicity of Lacosamide in Patients With Painful Chronic Pancreatitis
|
Phase 1 | |
Recruiting |
NCT04447976 -
Prospective Evaluation of Performance of Disposable Elevator Cap Duodenoscope During ERCP in Clinical Practice
|
||
Completed |
NCT03185390 -
Periampullary Lesions Via ERCP in Assuit University Hospital
|
N/A | |
Enrolling by invitation |
NCT03416205 -
A Prospective Study of Treating Duodenal Papillary Sphincter in Different Ways During ERCP
|
N/A | |
Recruiting |
NCT05211206 -
IV Fluids and Post-ERCP Pancreatitis
|
||
Not yet recruiting |
NCT04658212 -
A Multicenter Randomized Controlled Study of 3D Laparoscopy Versus Endoscopy in the Treatment of Choledocholithiasis
|
N/A | |
Terminated |
NCT02046590 -
RCT of Efficacy and Safety of Sedation Compared to General Anesthesia for ERCP
|
N/A | |
Recruiting |
NCT05219123 -
Guidewire Management in ERCP
|
||
Completed |
NCT00731198 -
Drotaverine Hydrochloride Versus Hyoscine-N-butylbromide for Duodenal Antimotility During Endoscopic Retrograde Cholangiopancreatography (ERCP)
|
Phase 3 | |
Completed |
NCT04167592 -
Benzydamine Hydrochloride Gargle in Reducing Propofol for ERCP
|
N/A | |
Completed |
NCT01873079 -
PPI for Prevention of Post-sphincterotomy Bleeding
|
Phase 3 | |
Not yet recruiting |
NCT05225909 -
aScope Single Use ERCP Study- ASSURE Study
|